S L Walsh
Overview
Explore the profile of S L Walsh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lofwall M, Moody D, Fang W, Nuzzo P, Walsh S
J Clin Pharmacol
. 2011 May;
52(4):600-6.
PMID: 21610203
No abstract available.
2.
Comer S, Ashworth J, Foltin R, Johanson C, Zacny J, Walsh S
Drug Alcohol Depend
. 2008 Apr;
96(1-2):1-15.
PMID: 18436394
The purpose of this review is to illustrate the utility and value of employing human self-administration procedures in medication development, including abuse liability assessments of novel medications and evaluation of...
3.
Walsh S, Chausmer A, Strain E, Bigelow G
Psychopharmacology (Berl)
. 2007 Oct;
196(1):143-55.
PMID: 17909753
Rationale: Butorphanol exerts activity at mu, kappa, and delta opiate receptors in rats and monkeys but produces predominant mu-like effects in humans. Objectives: The aim of this study was to...
4.
Costello D, Walsh S, Harrington H, Walsh C
J Neurol Neurosurg Psychiatry
. 2004 Mar;
75(4):631-3.
PMID: 15026513
Hereditary haemochromatosis (HH) is a genetic disorder in which abnormal iron handling leads to excessive iron accumulation in systemic tissues. Magnetic resonance imaging studies suggest excess iron deposition in the...
5.
Hood D, Cox A, Wakarchuk W, Schur M, Schweda E, Walsh S, et al.
Glycobiology
. 2001 Dec;
11(11):957-67.
PMID: 11744630
A genetic basis for the biosynthetic assembly of the globotetraose containing lipopolysaccharide (LPS) of Haemophilus influenzae strain RM118 (Rd) was determined by structural analysis of LPS derived from mutant strains....
6.
Evans S, Walsh S, Levin F, Foltin R, FISCHMAN M, Bigelow G
Drug Alcohol Depend
. 2001 Oct;
64(3):271-83.
PMID: 11672942
The effects of oral flupenthixol and intramuscular (i.m.) flupenthixol decanoate in combination with intravenous (i.v.) cocaine were evaluated in male cocaine abusers. Participants resided at an inpatient research unit for...
7.
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
Walsh S, Strain E, Abreu M, Bigelow G
Psychopharmacology (Berl)
. 2001 Oct;
157(2):151-62.
PMID: 11594439
Rationale: The availability of the highly selective and specific kappa opioid agonist enadoline provides an opportunity to explore the function of kappa receptors in humans and their potential utility as...
8.
Walsh S, Strain E, Bigelow G
J Pharmacol Exp Ther
. 2001 Sep;
299(1):147-58.
PMID: 11561074
Preclinical studies have demonstrated that kappa-opioid agonists can attenuate the neurochemical and behavioral effects of cocaine that are related to its reinforcing efficacy, suggesting that kappa-agonists may serve as pharmacotherapies...
9.
Donny E, Bigelow G, Walsh S
Psychopharmacology (Berl)
. 2001 Jul;
155(4):338-47.
PMID: 11441423
Rationale: Dopaminergic compounds have been targeted as potential treatments for cocaine abuse because of the known role of dopamine systems in drug reinforcement. Recent preclinical and human data have focused...
10.
Stoller K, Bigelow G, Walsh S, Strain E
Psychopharmacology (Berl)
. 2001 May;
154(3):230-42.
PMID: 11351930
Rationale: Buprenorphine is a partial mu opioid agonist under development as a sublingual (SL) medication for opioid dependence treatment in the United States. Because buprenorphine may be abused, tablets combining...